Clinical Trials
76 trialsActive Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer
M.D. Anderson Cancer Center
Integration of Neurocognitive Biomarkers Into a Neuro-Oncology Clinic
Baptist Health South Florida
ОС26
Military Medical Clinical Center of the Southern Region, Ukraine
Analysis of Different Second Line Treatment in Advanced NSCLC Patients Progressing After 1st Line Immune Checkpoint Inhibitor Therapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
RAINBO
Leiden University Medical Center
Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance
Roswell Park Cancer Institute
Alternative Splicing Based Prediction of Chemotherapy Response in Gastric Cancer
City of Hope Medical Center
De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA
Mayo Clinic
SPARE-1st
Eye & ENT Hospital of Fudan University
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Alliance for Clinical Trials in Oncology
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
NRG Oncology
Comparing Radiation Therapy to Usual Treatment for Patients With High-Risk Bone Metastases That Are Not Causing Pain, PREEMPT Trial
NRG Oncology
LAP100
NRG Oncology
MPN Childhood Registry
University of Erlangen-Nürnberg Medical School
SAVED LUNG
Centre hospitalier de l'Université de Montréal (CHUM)
The Enhancement of Diagnostic and Grading Efficacy of Prostate Cancer by New MRI Sequences: A Prospective Observational Study Based on New MRI Sequences in a Single Center
The First Affiliated Hospital of Soochow University
XAI-EGC
The First Affiliated Hospital of Soochow University
EECRTKI
University of Pisa
DMU-CH
Fenerbahce University
DIVINE
Mayo Clinic
Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment
Emory University
Active Surveillance for the Treatment of Low-Risk Basal Cell Carcinoma in Elderly Patients
University of Michigan Rogel Cancer Center
RESCUE
North Eastern German Society of Gynaecological Oncology
Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0)
Dana-Farber Cancer Institute
Communication Issues in Patient and Provider Discussions of Immunotherapy
Emory University
EURACAN
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Intelligence System for Predicting Atezolizumab-Bevacizumab Response and Clinical Outcomes in Unresectable Hepatocellular Carcinoma
First Affiliated Hospital of Wenzhou Medical University
GIVEN
Guangdong Provincial People's Hospital
RESOLBE
Clinica Universidad de Navarra, Universidad de Navarra
Pediatric Normative Markerless Movement Analysis
MultiCare Health System Research Institute
Impact of Postoperative Radiotherapy Versus PD-1 Inhibitor Maintenance on Survival in Resectable Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma
Zhujiang Hospital
An Observational Study for Gastric Cancer in Carriers of High Risk Helicobacter Pylori
Fudan University
GU-01
University of Illinois at Chicago
EULAT
Centre Paul Strauss
Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain
Mayo Clinic
An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry
Ohio State University Comprehensive Cancer Center
Estimating Jaw, Neck, and Shoulder Range of Motion Using an AI Model
National Taiwan University Hospital
The Efficacy of PD-1 Monoclonal Antibody Combined With Chemotherapy in Metastatic Gastric Cancer Based on Gut Microbiota
Fudan University
Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Mayo Clinic
Prospective Cohort Study on the Relationship Between Exosomal Peroxiredoxin 1 (PRDX1) and Postoperative Liver Metastasis
Shanghai Tongji Hospital, Tongji University School of Medicine
Integrated Clinical-molecular Risk Stratification to Early Recurrence in Colorectal Liver Metastases
Fudan University
DC/AML Fusion Cell Vaccine vs Observation in Patients Who Achieve a Chemotherapy-induced Remission
Beth Israel Deaconess Medical Center
A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan (CuSToMIze)
University of Michigan Rogel Cancer Center
TQ-BIRD
The University of Hong Kong-Shenzhen Hospital
LORD
The Netherlands Cancer Institute
Senolytics
Mayo Clinic
The Association Between Age-related Peripheral Blood Components and Treatment Efficacy in Breast Cancer
Fudan University
T-START-CR
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
RB SFCE 09
Institut Curie
SABR-SYNC
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's